Association and Mechanisms of Proton Pump Inhibitors Use with Type-2Diabetes Mellitus Incidence in Adults: A Systemic Review andMeta-Analysis.
Chenchula SantennaPhulen SharmaMohan Krishna GhantaKrishna Chaitanya AmerneniPadmavathi RajakarunakaranPavani SaggurthiMadhu Bhargavi ChandraRupesh GuptaMadhavrao ChavanPublished in: Current diabetes reviews (2024)
The systematic review concludes that chronic PPI exposure increases the risk of T2DM incidence. The authors recommend the shortest possible duration of PPI use and not prescribing PPIs to high-risk prediabetics and those without a compelling indication for PPI use. Regular education to patients regarding adverse reactions with prolonged use may decrease the risk of adverse effects associated with PPIs. The authors suggest that gut dysbiosis, hypergastrinemia, hypomagnesemia, decreased pancreatic secretions and IGF-1 levels, and PXR activation associated with chronic acid suppression among chronic PPI users and the potency of PPIs might explain the association between abnormal glucose metabolism and T2DM incidence. Finally, the authors recommend further randomized controlled trials to investigate the association between PPIs and the risk of new-onset T2DM incidence.
Keyphrases
- risk factors
- systematic review
- protein protein
- end stage renal disease
- randomized controlled trial
- primary care
- newly diagnosed
- healthcare
- chronic kidney disease
- small molecule
- drug induced
- clinical trial
- emergency department
- glycemic control
- peritoneal dialysis
- signaling pathway
- adipose tissue
- skeletal muscle
- study protocol
- pi k akt